Incode Technologies, the global leader in AI-powered identity verification and fraud prevention, today launched TrustGraph, the privacy-preserving trust network that enables institutions to detect ...
OXFORD, England, September 1, 2020 (Newswire.com) - GEN inCode UK Limited, the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular ...
SAN FRANCISCO, Nov. 8, 2022 /PRNewswire/ -- Incode Technologies Inc., the next-generation identity verification and authentication platform for global enterprises, today announced a strategic ...
OXFORD, England, January 7, 2021 (Newswire.com) - GEN inCode UK Limited the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, ...
OXFORD, England, April 28, 2021 (Newswire.com) - GEN inCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces today ...
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Extends its privacy-by-design architecture with ...
OXFORD, England, December 7, 2020 (Newswire.com) - GEN inCode UK Limited the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease ...
Incode, the next-generation identity verification and authentication platform for global enterprises, today announced it has raised $220 million in equity for its Series B funding round, giving the ...
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. A recognition we believe highlights Incode's ongoing ...
Incode provides a fully automated AI-powered platform that drives conversion while offering advanced fraud protection with the highest privacy and safety standards for global financial services, ...
Coronary Heart Disease (CHD) prevention nearly twice as effective when using CARDIO inCode as method to target treatment The study found that genetic and lifestyle factors are independently associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results